Emerging evidence suggests that transient epigenomic deregulation can establish stable cancer- or obesity-associated epigenetic fates, highlighting the need to understand mechanisms that sustain epigenetic stability. The small ubiquitin-like modifier (SUMO) regulates stemness, differentiation, and chromatin identity and has been implicated in tumorigenesis. Here, we investigate SUMOylation's role in epigenetic memory using the SUMOylation inhibitor TAK-981 (Subasumstat) and adipogenesis as a model. We show that transient SUMOylation inhibition in human adipose stem cells and mature adipocytes induces stable reprogramming of white adipocytes into beige adipocytes in a rosiglitazone-dependent manner. This reprogramming irreversibly upregulates the cAMP-PKA-p38 axis and stably remodels PPARG and PPARA enhancers, establishing a lasting epigenetic beiging fate characterized by upregulation of beiging genes, including UCP1, which induces mitochondrial uncoupling. SUMOylation is thus a key barrier to adipocyte reprogramming limiting both de novo beige adipocyte differentiation and white-to-beige transdifferentiation. Our data also suggest that combining TAK-981 with PPARG agonists could promote sustained, metabolically beneficial adipose tissue remodeling.